1. Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children
- Author
-
Zachary Kuschner, Clare L. Cutland, Shabir A. Madhi, Locadiah Kuwanda, Peter V. Adrian, Richard Madimabe, Keith P. Klugman, Marta C. Nunes, and Zelda Rabede
- Subjects
Male ,viruses ,HIV Infections ,Pneumococcal conjugate vaccine ,Cohort Studies ,Nasopharynx ,hRV, human-rhinovirus ,PIV, parainfluenza viruses ,Case fatality rate ,Prevalence ,hBoV, human-bocavirus ,PCP, Pneumocystis jiroveci ,Respiratory Tract Infections ,Randomized Controlled Trials as Topic ,hMPV, human metapneumovirus ,biology ,Respiratory tract infections ,Human bocavirus ,virus diseases ,PCV9 ,Infectious Diseases ,Pneumococcal pneumonia ,Female ,Polyomavirus ,rRT-PCR, real-time reverse transcriptase–polymerase chain reaction ,medicine.drug ,medicine.medical_specialty ,PCV9, 9-valent pneumococcal conjugate vaccine ,RCT, randomized placebo-controlled trial ,Article ,LRTIs, lower respiratory tract infections ,Human metapneumovirus ,Virology ,Internal medicine ,medicine ,Humans ,CFR, case fatality rate ,Polyomavirus Infections ,business.industry ,Infant ,HIV ,Respiratory infections ,Pneumococcal vaccine ,Pneumonia ,biochemical phenomena, metabolism, and nutrition ,Pneumonia, Pneumococcal ,VE, vaccine efficacy ,biology.organism_classification ,medicine.disease ,Polyomaviruses ,CoV, human-coronavirus ,Immunology ,PyV, polyomaviruses ,NPAs, nasopharyngeal aspirates ,RSV, respiratory syncytial virus ,business - Abstract
Highlights • HIV-infected and uninfected children with LRTIs were tested for WUPyV and KIPyV. • At least one polyomavirus was identified in 16% of specimens. • Polyomaviruses were frequently identified in association with other viruses. • Polyomaviruses may contribute to the pathogenesis of pneumococcal pneumonia., Background Two recently discovered polyomaviruses (PyV), WU and KI, have been identified in respiratory-tract specimens from children with acute respiratory infections, although there are limited data in HIV-infected children. Objectives To determine the prevalence and clinical manifestations of WUPyV and KIPyV-associated lower respiratory tract infections (LRTIs) hospitalization in HIV-infected and -uninfected children; and probe the role of pneumococcal co-infection. Study design Nasopharyngeal aspirates were collected from a cohort of 39,836 children randomized to receive 9-valent pneumococcal conjugate vaccine (PCV9) or placebo when hospitalized for LRTIs, and were screened by PCR for WUPyV, KIPyV and other respiratory viruses. Results In placebo-recipients the prevalence of WUPyV was 6.3% (18/285) in HIV-infected and 13.9% (66/476) in HIV-uninfected children (p = 0.002). In WUPyV-positive LRTIs HIV-infected children had lower oxygen saturation at admission and a higher case fatality rate (11.1% vs. 0%; p = 0.04). KIPyV was identified in 10.2% (29/285) of HIV-infected and in 7.4% (35/476) of HIV-uninfected placebo-recipients with LRTIs (p = 0.13). HIV-infected compared to HIV-uninfected children with KIPyV-positive LRTIs had lower oxygen saturation, higher respiratory rate and longer duration of hospitalization. Co-infections with other respiratory-viruses were detected in 65.5% of WUPyV-positive LRTIs and in 75.0% of KIPyV-positive LRTIs. Among HIV-uninfected children, there was a lower incidence of hospitalization for clinical pneumonia episodes in which KIPyV (80%; 95% CI: 41, 93) and WUPyV (49%; 95% CI: 9, 71) were identified among PCV9-recipients compared to placebo-recipients. Conclusions Polyomaviruses were commonly identified in HIV-infected and -uninfected children hospitalized for LRTIs, frequently in association with other viruses and may contribute to the pathogenesis of pneumococcal pneumonia.
- Published
- 2014
- Full Text
- View/download PDF